Multi-Turn Conversations and Prompts for Phase I Clinical Products

Phase I clinical research data primarily originates from Investigator's Brochures (IB), Clinical Study Protocols, Informed Consent Forms (ICF), and

Data Characteristics for This Category

Phase I clinical research data primarily originates from Investigator's Brochures (IB), Clinical Study Protocols, Informed Consent Forms (ICF), and Safety Reports. These documents are typically in PDF or Word format. Content is highly structured, including detailed mechanisms of action, toxicology data, pharmacokinetic (PK) and pharmacodynamic (PD) information, strict inclusion/exclusion criteria, and Adverse Event (AE) records. Data update frequency is relatively low, mainly occurring during protocol revisions, safety data accumulation, and annual report releases. Fields include dosage, administration route, subject characteristics (e.g., age, gender, weight), key biomarkers (e.g., Cmax, AUC), adverse event types, and severity. Units strictly adhere to international standards, such as mg, μg/kg for dosage, h, min for time, and ng/mL for concentration.

Constraints Imposed by These Characteristics on "Multi-Turn Conversations and Prompts"

The structured nature and high density of specialized terminology in Phase I clinical data demand extreme accuracy in domain-specific vocabulary recognition for multi-turn dialogue systems to understand user intent. This prevents misunderstandings caused by lexical ambiguity. The low data update frequency results in stable knowledge base content, reducing the pressure of frequent synchronization and indexing, but it requires robust historical version management. The detailed nature of documents means a single knowledge point may be distributed across multiple sections. The system needs cross-document and cross-chapter semantic association capabilities to support complex multi-turn follow-up questions. For example, a user might first ask about a drug's toxicity profile, then follow up with the incidence of a specific adverse event. This requires the system to extract data from safety reports and link it to the toxicological background in the Investigator's Brochure. Furthermore, strict unit and field specifications require the model to accurately cite data when generating responses, avoiding unit confusion or numerical errors. This directly impacts RAG retrieval accuracy and the reliability of generated content.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
Chunk size500–700 charactersEnsures each knowledge chunk contains sufficient context while avoiding excessive length that could disperse meaning.
Recall count7–10 entriesCovers a broader range of potentially relevant information, addressing the strong cross-document correlation of Phase I clinical data.
Similarity threshold0.78–0.85Balances precise matching with semantic generalization, filtering out low-relevance document segments.
Rerank result count3–5 entriesSelects the most relevant segments for in-depth analysis in multi-turn conversations, improving response quality.
maxContext8000–12000 tokenMaintains a longer dialogue history, supporting continuous user inquiries about drug details and preventing loss of critical information.
promptIncludes keywords like "I Phase Clinical", "Safety", "dosage Ramp-up"Guides the model to focus on the Phase I clinical domain, ensuring professionalism and accuracy of generated content.

Three Common Mistakes

  • Numerical errors or unit confusion in responses, such as misinterpreting mg as μg or h as min. This often occurs when knowledge base segmentation granularity is too large, preventing the model from accurately associating specific numerical values with their unit context.
  • After multi-turn conversations, the system's response quality to follow-up questions on the same topic deteriorates, or logical inconsistencies appear. This may be due to insufficient maxContext settings, leading to truncation of early conversation context and the model's inability to maintain long-term memory for complex issues.
  • When users ask about the incidence of specific adverse events, the system fails to provide accurate data or cites data from irrelevant study phases. This often happens because the Similarity threshold in the RAG retrieval phase is too high, or the knowledge base index lacks semantic enhancement for key fields (e.g., "adverse event type", "Incidence").

How to Confirm Proper Configuration

  • Conduct a series of simulated conversations to test whether the system can accurately answer core data points such as drug dosage, administration route, and incidence of specific adverse events. Verify numerical values and units.
  • Through long conversations, observe whether the system can maintain coherent and accurate responses to complex follow-up questions about drug mechanisms of action, PK/PD data after 5 or more turns. Evaluate the effectiveness of maxContext.
  • Deliberately pose questions with strong cross-document correlation, for example, first asking about drug toxicity, then about the clinical manifestations of corresponding adverse events. Check if the system can effectively integrate information from different knowledge sources.
  • Compare the system's responses to the same question in different dialogue turns. Confirm if there are response deviations due to context loss, and adjust maxContext and Chunk size accordingly.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.